FINAL PROGRAM - American Society of Gene & Cell Therapy

80American Society of Gene & Cell TherapyExhibitor DescriptionsNexcelom Bioscience360 Merrimack StreetBldg 9Lawrence, MA 01843Telephone: (978) 327-5340Fax: (978) 327-5341E-mail: ddemers@nexcelom.comWebsite: www.nexcelom.comBooth Number: 414Nexcelom’s Cellometer line of simple-to-use cell counters automate manual cellcounting procedures by obtaining accurate counts, viability, and cell sizes in lessthan 30 seconds & only 20uL of sample. Fluorescence detection capabilitiesenable fast & simple determination of GFP transfection rates, PI-viability, &direct counting of WBCs without lysing.NHLBI Gene Therapy Resource ProgramNational Heart, Lung, and Blood Institute, NIH2 Rockledge Center – 6701 Rockledge DriveBethesda, MD 20892-7940Telephone: (301) 435-0477Fax: (301) 480-7971E-mail: gtrpccc@s-3.comWebsite: www.gtrp.orgBooth Number: 311The NHLBI Gene Therapy Resource Program (GTRP) facilitates the translationof gene therapy research into clinical applications primarily in heart, lung, andblood diseases. Services provided by the program include preclinical and clinicalgradevector production, pharmacology/toxicology testing, immunology testing,regulatory support, and clinical trial funding assistance.NIH Office of Biotechnology Activities6705 Rockledge DriveSuite 750Bethesda, MD 20892Telephone: (301) 496-9838Fax: (301) 496-9839E-mail: oba@od.nih.govWebsite: http:\\oba.od.nih.govBooth Number: 508The NIH Office of Biotechnology Activities (OBA) promotes science, safety, andethics in biotechnology through advancement of knowledge, enhancementof public understanding, and development of sound public policies. OBAaccomplishes its mission through analysis, deliberation, and communication ofscientific, medical, ethical, legal, and social issues.NIH-RAID6001 Executive Blvd, Room 2141Bethesda, MD 20892Telephone: (301) 594-4660Fax: (301) 402-1501E-mail: nih-raid@mail.nih.govWebsite: http://nihroadmap.nih.gov/raid/Booth Number: 305NIH-RAID makes available, at no cost, certain resources needed for thedevelopment of new therapeutic agents. Available services include: production,bulk supply, GMP manufacturing, formulation, development of an assay suitablefor pharmacokinetic testing, and animal toxicology. NIH-RAID is not a grantprogram; successful projects gain access to government contract resources.Omnia Biologics, Inc.12111 Parklawn DriveRockville, MD 20852Telephone: (301) 984-5928Fax: (301) 984-2515E-mail: scardak@omniabiologics.comWebsite: www.omniabiologics.comBooth Number: 212Omnia Biologics provides cost effective outsourcing of product developmentservices to the biotechnology, pharmaceutical, and academic biologic drugdevelopers. These services include process development, cGMP cell and virusbanking, comprehensive cGMP manufacturing services, BSL-3 containment,assay development, formulation and fill/finish. Omnia has experience with avariety of vaccine, gene therapy and protein therapeutic platforms.Penn Vector Core125 South 31 st Street, Suite 2000Philadelphia, PA 19104-3403Telephone: (215) 573-0633Fax: (215) 573-0300E-mail: vector@mail.med.upenn.eduWebsite: http://www.med.upenn.edu/gtp/vector_core.shtmlBooth Number: 309Penn Vector Core is a state-of-the-art vector production facility for investigatorsboth within and external to the University of Pennsylvania. The main objective ofthe Core is to make various types of high quality viral vectors for gene transfer/Vaccine studies at the preclinical and basic research level.EXHIBITOR PROSPECTUSfinal program